Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium Chloride Injection for POAF in CABG
NCT06378021Phase 3Recruiting
- Sponsor
- Helwan University
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of calcium chloride in Atrial fibrillation (AFib) (2 arms), sponsored by Helwan University. Primary endpoint: Change in number of patients who developed Atrial fibrillation at 1 week. Started Mar 2024; status: recruiting.
02
Drugs
calcium chloride
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06378021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06378021.